Research identifies a protein group that may kick-start allergic reactions

What sets allergies in motion?

(Medical Xpress) -- Allergies, or hypersensitivities of the immune system, are more common than ever before. According to the Asthma and Allergies Foundation of America, one in five Americans suffers from an allergy — from milder forms like hay fever to more severe instances, like peanut allergies which can lead to anaphylactic shock.

While medications like antihistamines can treat the symptoms of an allergic reaction, the treatment is too limited, says Prof. Ronit Sagi-Eisenberg, a cell biologist at Tel Aviv University's Sackler Faculty of Medicine. Cells release dozens of molecules during an allergic reaction, and available medications address only a small subset. Now she and her fellow researchers are working to identify what triggers allergic reactions in the body, with the goal of stopping an allergic reaction before it starts.

The answer may lie within the Rab family, a group of 60 proteins that are known to regulate the distribution of proteins throughout the body. Along with her Ph.D. student Nurit Pereg-Azouz, Prof. Sagi-Eisenberg found that 30 of these proteins determined how cells react to an allergen, and two of these have been identified for further research as instruments of preventative medication. When the chain of events leading up to an allergic reaction can be understood, drugs can be developed to inhibit the initial reaction, explains Prof. Sagi-Eisenberg.

This research has been published in The Journal of Immunology.

Getting to the root

Allergic reactions can appear as rashes, respiratory difficulties, or swelling, but they're all caused by the same mechanism. When exposed to an allergen, the body activates the . But , located throughout the body, sense that the immune system has mistakenly been activated against something that is not bacterial or viral, and they release biologically active molecules to create an inflammatory response.

So what causes mast cells to react? Prof. Sagi-Eisenberg and her team work to identify the exact chain of events in an allergic reaction. They looked to the Rab family of proteins as a potential source for answers, screening for the proteins' involvement in initiating allergic reaction.

"We genetically manipulated mast cells so that they contained mutated versions of these proteins, which were already active without an allergen," explains Prof. Sagi-Eisenberg. If a was relevant, it would cause an allergic reaction. "This new methodology allowed us to screen for the functional impact of each member of this family, determining if they either inhibited or activated the allergic process."

In the end, the researchers flagged 30 proteins that were relevant to the process of creating an allergic reaction in the body, and have identified two that appear to be the most involved. Further research will use these two proteins as tools to gain more understanding of .

Targeted drugs could prevent allergic reaction

An allergic reaction is not only a function of two proteins interacting — it's the result of a chain of events. By identifying crucial links in such a chain, researchers can create targeted drugs that break the chain. New medications that target tumor cells, for example, are directed at halting the tumor's ability to function and grow, starving it of crucial blood and oxygen supplies. Prof. Sagi-Eisenberg envisions similar medications for allergies, with medications that address the source of the allergic reaction instead of the symptoms.

The need for such medications is pressing. Steroids, the only available type of drug that effectively prevents mast cells from secreting biologically active agents, also cause harm to kidneys, bones, and the immune system. Patients may suffer more from the treatment than they do from the itself. Alternative medications that are as effective as steroids but will be devoid of their adverse side effects are desperately needed. Prof. Sagi-Eisenberg's work will help to identify proteins that can be targeted by medications without impacting the function of other cells, she hopes.

Related Stories

New discovery may lead to new class of allergy drugs

Jan 29, 2009

If you've ever wondered why some allergic reactions progress quickly and may even become fatal, a new research report published in the February 2009 issue of the Journal of Leukocyte Biology provides an important part of the ...

Peanut allergy turned off by tricking immune system

Oct 11, 2011

Researchers have turned off a life-threatening allergic response to peanuts by tricking the immune system into thinking the nut proteins aren't a threat to the body, according to a new preclinical study from Northwestern ...

Allergic-like reactions occur in premedicated patients

Feb 09, 2008

Allergic-like reactions can occur in patients (both children and adults) when given gadolinium containing contrast agents, even if they have been pre-medicated with corticosteroids and antihistamines, according to a recent ...

Recommended for you

New hay fever blood test nothing to sneeze at

Sep 29, 2014

(Medical Xpress)—Brisbane researchers have developed a blood test that can accurately detect one of the commonest causes of hay fever, paving the way for new treatments.

Geisel researchers contribute to study of trained immunity

Sep 26, 2014

A study published in the journal science provides support for a new—and still controversial—understanding of the immune system. the research was conducted by collaborators in the U.S. and Europe, including Robert Cramer ...

New app offers relief for hay fever sufferers

Sep 25, 2014

Hay fever and asthma sufferers in Canberra will soon be able to receive daily counts and forecasts of pollen levels thanks to a free app released by ANU researchers.

User comments